Sanofi

Business in russia — Operating in russia

According to its 20-F annual report (filed with the SEC on 17 February 2026), Sanofi still holds the capital of the russian entity Opella Russie and continues to distribute Opella products in russia under a distribution agreement signed in connection with the separation of that business. This is company-reported information; no court finding of fault exists.

  • subject, 2026-02-17
  • kse, 2025-12-08